The ability to erect rationally-engineered reproductive barriers in animal or plant species promises to enable a number of biotechnological applications such as the creation of genetic firewalls, the containment of gene drives or novel population replacement and suppression strategies for genetic control. However, to date no experimental data exist that explores this concept in a multicellular organism. Here we examine the requirements for building artificial reproductive barriers in the metazoan model Drosophila melanogaster by combining CRISPR-based genome editing and transcriptional transactivation (CRISPRa) of the same loci.
Introduction
The advent of the CRISPR/Cas9 technology has provided the means to modify genomes with unparalleled specificity and accuracy in a wide variety of model and non-model organisms [1] [2] [3] [4] [5] [6] [7] [8] [9] . These advances in genome engineering, besides enabling a wave of basic research, have also been applied with the aim of distorting inheritance in insect disease vectors. CRISPR gene drives 1, 10 and sex-distorters 11 are currently being considered for their enormous potential to control harmful organism such as the malaria vector Anopheles gambiae. The CRISPR machinery now broadly employed for gene editing in many organisms, has recently been modified to manipulate the transcriptome; namely targeted gene transactivation and repression. CRISPR gene activation (CRISPRa) uses a nuclease-deficient, deactivated Cas9 (dCas9) protein, fused to a transactivation domain which recruits the basal transcriptional machinery to the site of sgRNA complementarity [12] [13] [14] [15] [16] [17] .
This expanded CRISPR toolset now allows for the exploration of more radical genetic engineering concepts one of which is the design of artificial reproductive isolation and the generation of synthetic species. The potential applications of artificial reproductive isolation and synthetic species have been discussed elsewhere 18 . Briefly, the prevention of undesired flow of genetic information is a major concern for the field of biotechnology. The introgression of transgenes from Genetically Modified Organisms (GMOs) into the gene-pool of their native counterparts, or the escape of gene drives could be counteracted by this technology. Alternatively, since the synthetic species and its parent species are assumed to be largely identical one can replace the other in a process that is aided by the engineered incompatibility of hybrids. This combination of population suppression and replacement has attractive features in that the release strain requires no special rearing conditions or sterilization. At an even larger scope, there are possible applications in ecosystem engineering 19 , e.g. the ability to close and open the reproductive barriers between closely related mating groups and the ability to introduce newly designed species are powerful concepts for environmental management.
Constructing an artificial reproductive barrier requires first the identification of an upstream enhancer or promoter region that allows for lethal, ectopic transactivation of an endogenous gene when targeted by a synthetic transcription factor. It also requires a second modification, the creation of an analogous refracto-ry enhancer region, designed to prevent synthetic transcription factor binding. In this way synthetic lethality is triggered by the transgene in hybrids that result from a cross between modified individuals and those of the naive genetic background. This approach is in principle generalizable and could work in any tractable sexually reproducing organism, because it circumvents the need to research and employ species-specific modes of incompatibility or interfere with endogenous regulatory pathways in order to engineer isolation.
This concept has been recently tested in yeast cells using the ACT1 gene 18 . In this study, the dCas9 Synergistic Activation Mediator (SAM) system was used to over-expression Actin, which resulted in loss of cellular integrity when dCas9 strains were mated to wild-type 18 , although cells that escape synthetic lethality were observed. This work also highlights that the majority of experimental work utilizing dCas9 with a view to application remains cell-based 20,21 with it's potential in complex systems largely unexplored.
In the present study we combined CRISPR gene editing and transactivation, to explore the design of engineered reproductive barriers in a multicellular organism and to study their properties. Using Drosophila melanogaster as a model, we sought to achieve synthetic lethality in crosses with the wild-type by targeted miss-expression of genes known to be essential for fly embryo development ( Figure 1 ). We reasoned that temporal and spatial perturbations of precisely orchestrated wild-type expression patterns during embryogenesis could result in developmental arrest and lethality. We sought to design sgRNAs targeting genes that function during embryogenesis, and couple these with dCas9 transcriptional activators to trigger embryonic lethality. By coupling these same sgRNA with Cas9 expressed in the germline we sought to isolate protective mutations that suppress inactivation, and then combine these genetic elements into engineered reproductive barriers.
Results

Design of the sgRNA panel and dCas9 activation strategy
We first constructed and tested components for ectopic transactivation of target genes in Drosophila, and evaluated the degree of transactivation. We designed a panel of 13 sgRNAs (18-20bp) targeted to candidate upstream promoter and enhancer regions of 7 developmental genes in the Drosophila genome, namely dpp, engrailed, eve, hairy, hid, rad51 and reaper (Figure 2A ). Most sgRNAs were designed to bind close to the Transcriptional Start Site (TSS) within a window of 150 bp upstream to 48 bp downstream of the TSS, with some sgRNAs targeting known intronic enhancers. We combined these sgRNAs with three distinct dCas9 activator domain fusions (Supplementary Figure 1B) : the dCas9-VPR fusion, which has been reported to give robust transactivation in Drosophila cells 21 and tissue 22, 23 . The dCas9-P300 Core, a histone acetyltransferase domain, which is capable of activating from promoters and distal enhancers to levels greater than VP64 in HEK cells, but had not yet been tested in Drosophila 24 . Finally, we also used a 634AA region of the P300 Drosophila orthologue Nejire, which has 77% sequence identity (Supplementary Figure 1A ) with P300 Core, as a C-terminal fusion to Human codon optimized S.pyogenes dCas9 (containing nuclease-inactivating mutations D10A and H840A) (Supplementary Figure 1B) .
dCas9 transactivation by sgRNAs in the Drosophila eye
First, we benchmarked the activation potential of our dCas9 sgRNA combinations using the UAS/GAL4 system 25 in the Drosophila eye ( Figure 2B , Supplementary Technical Cross 2A), where our target genes do not exhibit a significant level of expression. Testing the entire panel of sgRNAs in combination with dCas9-VPR, we found a 112 fold increase in eve expression, using a sgRNA directed to the eve promoter (eve-sgRNA).
The eve gene is a pair rule patterning factor expressed during embryogenesis and nerve cells in the fly brain, and it is not expressed in wild-type eyes [26] [27] [28] [29] . By comparison, the sgRNAs for dpp4, dpp5, engrailed, hairy, hid1, hid2, rad51, reaper2 increased the expression of their target genes at more moderate levels ( Figure   2B ). The sgRNAs dpp1, dpp2, dpp3 and reaper2 were found to suppress gene expression compared to contols, possibly due to binding competition and steric-hindrance with cis-regulatory factors at the site of tran-scription (dpp 30 and reaper 31, 32 are both known to play a developmental role in wild-type eyes). Subtle increases in the expression of developmental genes induced through dCas9-VPR are known to have pronounced developmental phenotypes when expressed in Drosophila tissues 23 . The eve-sgRNA in complex with dCas9-VPR did induce a moderately aberrant eye phenotype ( Figure 2D ), however no pronounced aberrant eye phenotype was observed with dCas9-VPR with the sgRNAs targeting the other genes. We next compared by qRT-PCR our panel of activation domains using the eve-sgRNA. While dCas9-P300 Core yielded no detectable increase in eve transcript in the eye, dCas9-Nejire Core triggered an 845 fold increase a significantly stronger induction than the already pronounced effect of dCas9-VPR ( Figure 2C , Supplementary Technical Cross 1A-C). As expected, the combination of dCas9-Nejire Core with the eve-sgRNA resulted in a severe eye-developmental mutant phenotype ( Figure 2D ). The remaining sgRNAs in combination with dCas9-Nejire Core expressed in eyes all showed abnormal developmental phenotypes ( Supplementary Figure 1C) . These results indicate that dCas9-Nejire Core is a powerful tool to over-express genes in flies using sgRNAs. Even those sgRNAs which did not increase gene expression in conjunction with VPR showed developmental phenotypes consistent with over-expression by Nejire Core. For example three sgRNAs were targeted downstream of the TSS in the dpp intron, dpp3 and dpp4 target 5' of the Dorsal-bound Ventral Repressive Element S3, dpp5 binds 5' of VPE S4. Dorsal binds to VPEs in the ventral side of the developing embryo 33 to repress dpp expression, which recruits co-factor Groucho 34 to repress dpp at the promoter. Nejire Core induces developmental phenotypes when targeted to dpp2, 3, 4-sgRNA binding sites. This is consistent with studies with P300 Core in HEK cells which show that P300 Core is capable of activating transcription from distal enhancers whereas as VP64 cannot 24 . However, because dCas9-Nejire Core exhibited a subtle but reproducible eye phenotype even in the absence of sgRNAs we decided, in the context of this study, to focus on dCas9-VPR for the remaining experiments.
Miss-expression screen during early fly development using dCas9
We next tested our sgRNAs against a panel of GAL4 drivers expressing dCas9-VPR, in a screen for developmental arrest/lethality during early stages of Drosophila development ( Figure 3A ). The sgRNAs assayed for activation potential were crossed to a panel of GAL4 driver lines that exhibit diverse temporal/spatial, em-bryonic, larval or ubiquitous expression patterns. GAL4 lines were maintained over dominant balancers, the inheritance of which was scored in the F1. This allowed for the identification of GAL4-sgRNA combinations-in the presence of UAS::dCas9-VPR-giving full or partial lethality during embryogenesis and/or larval development (Supplementary Technical Cross 3A-E, Supplementary Tables 1-3 ). Ubiquitous expression throughout tissues and at all developmental time-points with pαTubulin-84b-GAL4 driving dCas9-VPR gave complete embryonic lethality with sgRNAs eve, hid1, hid2 at room temperature; dpp2, 3, 4, 5, engrailed, eve, hid1 and hid2 at 25°C and all sgRNAs except hairy and reaper1 at 29°C ( Figure 3A ). Temperaturedependent increases in lethality were seen with dpp1 and rad51 from 25°C to 29°C and dpp2, 3, 4, 5 between room-temperature and 25°C (and 29°C). As it is known that GAL4 activity increases with temperature 25 , we also performed control crosses to lines lacking sgRNAs and showed that elevated temperatures alone do not increase background lethality ( Supplementary Table 3 ). This suggests that the activation potential of certain sgRNAs may be limited by the level of dCas9-VPR, even when dCas9-VPR is ubiquitously expressed. It is likely that increased genome binding events would lead to increased lethality, rather than increased activity of the VPR domain. This is suggested by the observation that dpp1, 2, 3 and reaper1 show temperature dependent increases in lethality ( Figure 3B ) yet were found to reduce target gene expression in the eye ( Figure 2B ). The eve-sgRNA was found to give complete lethality in all driver conditions except in combination with 3.1lsp2, pannier and spalt. This correlates with the strong eve over-expression exhibited by eve-sgRNA when measured in eyes ( Figure 2B ).
Analysis of eve miss-expression during embryo development
To link this set of observations we analyzed eve mRNA and protein expression in the context of the developing embryo (Supplementary Technical Cross 5). We first quantified embryonic eve and hid overexpression by qRT-PCR ( Figure 3C ) and found that, the presence of eve-sgRNA results in an 80 fold increase and hid1-sgRNA a 2.75 fold increase in early development, levels that correlate well with the expression in the eye ( Figure 2B ). In the presence of eve-sgRNA antibody staining showed pervasive Eve over-expression in the early embryo (stage 6-7) outside its native spatiotemporal range as a pair-rule regulator ( Figure 4B ).
In later stage wild-type embryos (stage 14-15) Eve protein is found in the posterior (anal pad) region and in the mesoderm along with a subset of neuronal nuclei 27 . Lines which express the eve-sgRNA with dCas9-VPR also exhibit ectopic Eve expression throughout the embryo at this stage ( Figure 4F ). At this later stage Eve miss-expression is associated with a developmental delay and signs of disorganization of the embryos (Figure 4J) , which subsequently fail to hatch.
Generation and analysis of protective INDELs using Cas9
In parallel we performed CRISPR/Cas9 mutagenesis to identify INDELs in the targeted gene regions that would abolish sgRNA binding at the target sites, but which would be tolerated in the context of target gene function ( Figure 5A ). One sgRNA per gene from the panel of sgRNA flies were crossed to pvasa::Cas9 expressing lines. Progeny were crossed to appropriate balancer lines and screened for INDEL mutations at the sgRNA binding site by PCR (Supplementary Technical Cross 4A, B). F2 progeny were then tested for homozygote mutant viability, fitness and fertility ( Figure 5B ). We found that all sgRNAs tested resulted in the production of INDEL mutations. This confirms that the lack of significant transactivation observed in certain conditions with dCas9-VPR can't be attributed to sgRNA function. We found that mutations dpp2-1, dpp2-4
and eve-16 resulted in a significant reduction in fitness and the complete loss of female fertility. Only a single mutation reaper1-9 was found to cause homozygous lethality. All other INDEL mutations were viable as homozygotes with no obvious fitness cost observed. Although our sgRNA panel was designed to avoid known regulatory elements within the target loci, it is possible that dpp2-1, dpp2-4 and eve-16 mutations disrupt cis-regulatory sequences needed for germ-line development in female flies and an essential developmental process in the case of reaper1-9.
Combining transactivators with protective INDELs
Next we incorporated lethal components identified in the CRISPRa screen into single expression plasmids containing dCas9-VPR under the direct control of four different promoters: ptwist (TW), phow (H), pαTubulin-84b-Long (LT) and pαTubulin-84b-Short (ST) (Supplementary Figure 2) . The plasmids also contained the eve-sgRNA expressed ubiquitously under the control of the U6::3 regulatory regions. These constructs therefore target a single locus, in this case eve, and designed to form a single barrier (SB) to hybridization.
Embryos homozygous for the eveΔ11 mutation, which had no impact on gene function ( Figure 5B ) were injected with the expectation that this mutation would render them resistant to the effects of the lethal components. Constructs were either integrated at genomic AttP docking known to exhibit high expression from integrated transgenes [35] [36] [37] , or by using P-element random integration and positive transformants were back-crossed to obtain, if possible, homozygous inserts. Using the Mini-White dominant marker we scored for synthetic lethality by crossing to white-eyed w1118 flies with an unmodified eve target locus (which we refer to as wild-type in this context). Figure 6 summarizes the outcome of these experiments and the genetic crossing strategy is detailed in Supplementary Technical Cross 6A-C. Transgenic strains with dCas9-VPR driven by pαTubulin-84b-Long when crossed to wild-type display the full range of possible phenotypes ranging from no observable effect on viability to complete synthetic lethality in the case of line SB-LT. Synthetic lethality of line SB-LT is completely rescued in crosses to homozygous eveΔ11 mutants. The SB-TW line conferred ~48% lethality whereas the SB-H line was found to confer no significant lethality. We found that few pαTubulin-84b-Long strains were homozygous viable. This is likely because of a significant fitness costs associated with ubiquitous dCas9-VPR tissue expression. For other lines such as SB-H, SB-TW and SB-ST homozygous expression of the activator was possible, but it induced more moderate levels of genetic isolation.
Our genetic strategy also allows for the stacking of genetic barriers. To attempt this we chose to combine eve and hid1-sgRNAs into a single vector. We combined mutants eveΔ11 with hid1-Δ13 into a genetic background with double-refractory promoter regions in homozygosis. We then inserted into this backgroundusing P-element integration-a vector expressing dCas9-VPR from pαTubulin-84b-Long along with eve and hid1-sgRNAs expressed from U6::3. We attempted this with U6::3 regulatory regions flanking each sgRNA in tandem (DB1 constructs) and also with a tRNA separating sgRNAs to allow for post-transcriptional cleavage of sgRNAs (DB2 constructs) ( Figure 6, Supplementary Figure 2 ). We observed 50% lethality with the tandem DB1 construct when crossed as a heterozygote to a 'wild-type' background. We then performed separate crosses to the eveΔ11 and also hid1-Δ13 homozygous backgrounds as well as the double-homozygous eveΔ11 & hid1-Δ13 stock and confirmed that synthetic lethality induced by both sgRNAs (Figure 6 ), albeit moderate overall, is additive and synergistic.
Discussion
The concept of artificial reproductive isolation or "synthetic species" has been investigated previously 38 in Drosophila. However in the pre-CRISPR era, it required the exploitation of complex fly genetics and knowledge of unique biological aspects of the Drosophila glass gene. This strategy therefore could not easily be applied to other species or even other loci. One of the principle attractions of the approach we present here, is that it achieves synthetic lethality through minimal modifications of evolutionary conserved loci using the expanded CRIPSR toolset that is now available in a range of organisms. This strategy should facilitate the transfer of this technology to diverse organisms and the rational design of genetic isolation.
Recently, a similar strategy was tested in a proof-of-principle in the lower unicellular eukaryote S.cerevisiae; yeast however requires comparatively fewer and less complex genetic engineering steps than higher eukaryotes 18 .
Our survey of protective mutations and lethal CRISPRa elements suggests that protecting genomes from transactivation can be achieved at most loci, as INDELS rarely seem to affect nearby cis-elements in the promoter or enhancer regions. Isolating a range of INDELS at a target site is straightforward and allows the selection of those that have no negative effects. Achieving synthetic lethality through transactivation by CRISPRa was more challenging, and whilst all sgRNAs used for gene editing yielded INDEL mutations, not all drive strong gene activation. In this study we directed single sgRNAs to enhancer regions and found in most cases a less than 2-fold increase in mRNA levels with one notable expression being the eve-sgRNA which to our knowledge leads to the highest increase in gene activation for a single sgRNA tested in vivo. This highlights that whilst there are some parameters for the design of effective sgRNAs for DNA cleavage, knowledge of what makes a sgRNA particularly effective at transactivation is still lacking 39, 40 . It has been reported that targeting sgRNAs within 400bp upstream of the transcriptional start site is effective in some contexts, but clearly such positioning alone is insufficient to guarantee strong activation 17 . It has been shown that when multiple sgRNAs are targeted to a promoter the probability of achieving biologically relevant transactivation is increased 22 . However, it has also been shown that when multiple sgRNAs are targeted to a promoter, the effect on transactivation is not synergistic, and can be mostly attributed to a single highly active sgRNA 22 . On the other hand it has also been demonstrated that a significant number of sgRNA pairs that target within this window generate observable phenotypes with dCas9-VPR despite relatively modest increases in gene product in some cases 23 . Consistent with this, we observed lethality with most sgRNAs when dCas9-VPR is expressed by a ubiquitous GAL4 driver. It is likely, that assaying mRNA expression levels on a tissue aggregate level may overlook more pronounced transactivation in particularly receptive cell types. For example, it has been reported that chromatin accessibility may prevent the binding Cas9 and the binding of synthetic transcription factors at transcriptionally inactive loci 41, 42 . Therefore targeting genes for transactivation in tissues which show low basal levels of expression may be a more effective approach to obtaining sgRNAs capable of strong activation with VPR. It also suggests a role for directed chromatin modifiers which could yield activation for some loci that are refractory to transactivation by more traditional activation domains such as VPR. We found that all sgRNAs tested with dCas9-Nejire Core led to morphological phenotypes when the transactivators were expressed in the eye, which was not the case with dCas9-VPR. As expression of dCas9-Nejire Core had subtle developmental phenotypes in the absence of sgRNAs it likely triggered non-specific effects that are too strong to allow it to be used in the context of generating reproductive barriers at present. However, for other applications, and possibly with further modifications to modulate its strength, it could become a powerful building block for the in vivo CRISPRa toolbox.
We tested the synthetic lethality of single-vector CRISPRa constructs established in a genetic background homozygous for protective mutations. To obtain lines harboring elements which could not be inherited in crosses to wild-type required a ubiquitous expression pattern of dCas9-VPR using pα-tubulin. However, ubiquitous expression by pα-tubulin when associated with strong synthetic lethality also precluded the generation of viable homozygotes and thus full genetic isolation of the strain. We achieved a medium level of synthetic lethality in combination with homozygous viability with ptwist driven dCas9-VPR. In our missexpression screen ptwist had previously triggered complete lethality with eve-sgRNA, and it is likely that the lack of the GAL4 amplification loop accounts for this difference. As expected, we also detected varying levels of synthetic lethality with identical constructs depending on the insertion site, suggesting that the genetic context may modulate CRISPRa penetrance.
Whilst we didn't explore the use of multiple stacked genetic barriers in great detail beyond demonstrating a proof-of-principle, their use will likely be a necessity for any realistic application of engineered reproductive isolation. Genetic diversity in large wild-type populations means that circulating rare variants at the sgRNA target sites could abrogate synthetic lethality and lead to the generation of escapers and the eventual breakdown of genetic isolation. By combining two sgRNA activators with their corresponding protective mutations, genetic isolation could be fortified to safeguard against failure through rare recombination, random mutations within the constructs or transgene silencing events. As a proof of principle we demonstrate that using eve and hid1-sgRNAs allows for stacking of single transactivation elements to induce synergistic effects on synthetic lethality.
We suggest that fine tuning the approach presented here will likely require the refinement of the expres- DEL mutants for each sgRNA tested. Some independent isolated mutant lines screened were found to contain identical lesions; this is the case for dpp2-3/5, engrailed-1/2/3, engrailed-5/17/99, eve-2/3/11, eve-13/14 and hairy-3/10. PAM sequence is shown in blue, sgRNA binding site shown in red, deletions by black hyphen, insertions shown in orange. 
Materials and Methods
sgRNA design and cloning
The flyCRISPR Target Finder tool (http://tools.flycrispr.molbio.wisc.edu/targetFinder/) was used to identify 18-20nt sgRNA binding sites in genomic regions of interest. DNA sequences were obtained from FlyBase. All sgRNA candidates which overlapped with known transcription factor binding sites (annotated by the modenCODE and RedFly projects) were disregarded to avoid interfering with endogenous transcriptional control. sgRNAs were cloned into the pCFD3 vector, under the control of U6::3 regulatory regions (as reported by Port et al) 8 . pCFD3 vectors were incorporated at AttP-9A sites (VK00027) on the third chromosome 36 .
GAL4 transactivation experiments
The how-GAL4 and GMR-GAL4 UAS::dCas9-VPR driven line was created by crossing UAS::dCas9-VPR lines 
Generation of INDEL mutations
To induce INDELs at sgRNA target sites in the genome (see Supplementary Technical Cross 4A and 4B) Balancer) if no fitness cost were associated with the INDEL. If complete non-absence of balancer was observed then homozygous lethality was assumed. If significantly fewer non-balancer homozygous INDELs were observed in the F3 generation the line was considered to have a fitness cost; in this case progeny were counted from individual crosses between two balanced individuals and the chi-squared test used to ascertain if the incidence of non-balanced F1 individuals were significantly less than the expected ratio of 1:2. For lines with reduced fitness, homozygous INDEL flies were crossed to balancers in a reciprocal manner to assess male/female sterility.
at 4°C with primary antibodies for Eve (3C10-DSHB, from mouse), late stage embryos were also incubated with FLAG (Sigma -F7425, from rabbit) to identify expression from UAS::FLAG-dCas9-VPR. Embryos were then incubated for 2 hours with secondary antibodies: donkey anti-mouse Alexafluor-488 and donkey antirabbit Alexafluor-594 (Thermo-Fisher). Embryos were mounted in 50% glycerol containing DAPI counterstain. Confocal images were obtained on a Zeiss LSM-510 inverted confocal microscope, Z-stack images were created using Fiji software. All settings were uniform when collecting and analyzing both control and sample micrographs at stage 6-7 and stage 14-15 respectively.
Construction of dCas9-P300 Core and dCas9-Nejire Core
UAS::dCas9-VPR in pWalium20 (Gift from Norbert Perrimon) was digested with BstAPI and EcoRI to remove the VPR domain. A C terminal section of dCas9 is also removed by this digestion. Gibson Assembly primers were used to amplify the fragment of dCas9 removed by cleavage at the EcoRI site by PCR using pWalium20 as a template (Primers 'GIB-Nejire Frag 1 F+R' and 'GIB-P300 Frag 1 F+R', Supplementary Primers). Gibson
Assembly primers ('GIB-P300 Frag 2 F+R') were used to amplify P300 Core from Addgene vector 61357 as template. Gibson Primers ('GIB-Nejire Frag 2 F+R') were used to amplify the identified Nejire Core region from a Drosophila melanogaster whole body cDNA library of w1118 flies. Digested and gel-purified pWali-um20 was incubated with appropriate Gibson Assembly PCR products at a molar ratio of 1:3 (Vector:Insert) using 50ng of vector DNA. Reactions were performed using the Gibson Assembly Cloning Kit (NEB). See Supplementary Primers for sequence information.
Construction of transactivation vectors
A combination of restriction enzyme digestion, PCR, ligation, Gibson Assembly and Gateway recombination were used to construct transaction vectors. UAS::dCas9-VPR in pWalium20 was digested with NheI and SpeI to remove the 10xUAS sequence, the backbone was gel purified and blunt-ended with dNTPs and T4 DNA polymerase (NEB). The blunted backbone was ligated to Gateway Destination vector conversion fragment reading frame B (Thermo-Fisher) to replace UAS with an AttR1-AttR2 ccdB containing cassette. pWalium20 contains an AttB sequence for integration at AttP docking-sites in Drosophila. To enable P-element integra-
